Botanix Pharmaceuticals (ASX:BOT) EPS (Basic) : A$-0.02 (TTM As of Dec. 2024)

View and export this data going back to 1985. Start your Free Trial

What is Botanix Pharmaceuticals EPS (Basic)?

Botanix Pharmaceuticals's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was A$-0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.02.

Botanix Pharmaceuticals's EPS (Diluted) for the six months ended in Dec. 2024 was A$-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.02.

Botanix Pharmaceuticals's EPS without NRI for the six months ended in Dec. 2024 was A$-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -0.02.

During the past 3 years, the average EPS without NRI Growth Rate was -44.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Botanix Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 84.10% per year. The lowest was -96.90% per year. And the median was 26.30% per year.

Botanix Pharmaceuticals EPS (Basic) Historical Data

The historical data trend for Botanix Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Botanix Pharmaceuticals EPS (Basic) Chart

Botanix Pharmaceuticals Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

EPS (Basic)

Get a 7-Day Free Trial

-0.02

-0.01

Botanix Pharmaceuticals Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															-0.01	-	-	-0.01	-0.02

Botanix Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Botanix Pharmaceuticals's Basic EPS for the fiscal year that ended in Jun. 2024 is calculated as

Basic EPS (A: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-13.87	-	0)	/	1501.564
	=	-0.01

Botanix Pharmaceuticals's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-30.888	-	0)	/	1816.948
	=	-0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.02

Botanix Pharmaceuticals (ASX:BOT) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Botanix Pharmaceuticals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Botanix Pharmaceuticals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Botanix Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Botanix Pharmaceuticals Ltd (ASX:BOT) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

BXPHF:USA

Address

41 - 47 Colin Street, Suite 3, West Perth, WA, AUS, 6005

Website

https://www.botanixpharma.com

Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia.

Botanix Pharmaceuticals Headlines

No Headlines